STAT Summit: How researchers deal with rejection
Fromlefttoright:BrendaCabrera-Mendoza,LaurenGhazal,andZhiYuatthe2023STATSummit.STATAttheageof26,Laur
-
Medical records are filled with copy
-
Merck, Daiichi strike cancer drug pact worth up to $22 billion
-
Cancer drug shortages should be causing more outrage
-
Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags
-
Virginia high school admissions case could be legal follow
-
UnitedHealth, Optum discontinue NaviHealth name
Elon Musk announces 'temporary limits' for reading Twitter posts
0:53TheTwitterlogoisseenonaphoneinthisphotoillustrationinWashington,D.C.AlastairPike/AFPviaGettyImag
The high cost of giving birth even with insurance
- What does generative AI mean for health care? We asked experts
- Health tech investors get more selective as pandemic boom fades
- Tori Bowie and the unacceptable rates of Black maternal death
- PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works
- Hollywood unions extend contract negotiations for actors
- Masked assailants attack a journalist and a lawyer in Russia's Chechnya province
- Bright Health sells Medicare Advantage business to Molina
- Chicago flooding is stark reminder of vulnerability of major cities during extreme weather
- In Memoriam: Notable people who died in 2023
- US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage
- Anesthesiologist group: stop taking Ozempic before surgery
- Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation
- 23andMe had bad news about my health. I wish a person had delivered it
- Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida
- State Dept. review finds Biden bears some blame for Afghanistan failures
- The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies
- After affirmative action ruling, medical educators look to 'holistic review'
- Roivant's CEO is a star, but biotech's black hole persists
- Moonlake's readout produced a cash windfall. Risks remain
- 10 states plan to sue EPA over standards for residential wood
- Medicare details structure of new drug price negotiation program
- STAT Summit: Ending the crisis of Black deaths in the U.S.
- Dobbs anniversary: the lost opportunity of abortion as health care
- Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal
- FDA approval of Sarepta Duchenne genetic therapy gives me hope
- Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal
- Medical records are filled with copy
- EU climate chief is concerned over the expansion of the coal industry in China
- At least 13 dead in Texas as scorching temps continue
- Smaller biotechs seek to piggyback on weight loss drug boom
- Dobbs anniversary: the lost opportunity of abortion as health care
- Why a market frenzy over new weight loss drugs defies logic
- The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies
- Roche acquires Telavant from Roivant, adding experimental IBD treatment
- STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots
- STAT Readout: Friday, Oct. 20 biotech updates
- 4 dead, 2 in stable condition in Philadelphia shooting: Police
- Results on Novartis prostate cancer therapy could expand its use
- Smaller biotechs seek to piggyback on weight loss drug boom
- Merck, Daiichi strike cancer drug pact worth up to $22 billion
Roivant's CEO is a star, but biotech's black hole persists
- Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags
- The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies
- Readout LOUD podcast: Live from the 2023 STAT Summit
- Roche drug slashes death risk in early
- Russians and Belarusians back at Wimbledon as war in Ukraine continues
- STAT Summit: Meghan O’Rourke on making chronic illness visible
- Roche acquires Telavant from Roivant, adding experimental IBD treatment
- 4 dead, 2 in stable condition in Philadelphia shooting: Police
- Merck, Daiichi strike cancer drug pact worth up to $22 billion
- STAT Summit: Meghan O’Rourke on making chronic illness visible
- Leon Gautier, last member of French D
- Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags
- Elon Musk announces 'temporary limits' for reading Twitter posts
- Cassava Sciences’ Alzheimer’s clinical trials should be halted
- UnitedHealth, Optum discontinue NaviHealth name
- Readout LOUD podcast: Live from the 2023 STAT Summit
- 10 states plan to sue EPA over standards for residential wood
- STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots
- Health tech investors get more selective as pandemic boom fades
- Why a market frenzy over new weight loss drugs defies logic
- Russians and Belarusians back at Wimbledon as war in Ukraine continues
- STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots
- Cassava Sciences’ Alzheimer’s clinical trials should be halted
- STAT Summit: Ending the crisis of Black deaths in the U.S.
- Russians and Belarusians back at Wimbledon as war in Ukraine continues
- Cassava Sciences’ Alzheimer’s clinical trials should be halted
- NASA releases new images of 'fingerprint
- Is there really a nursing shortage in the U.S.?
- Study on Amgen’s bispecific immunotherapy produces positive data
- Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich
- Harvard's Jason Buenrostro wins MacArthur grant for genetics work
- Churchill Downs extends trainer Bob Baffert's ban through 2024
- Health tech investors get more selective as pandemic boom fades
- Merck, Daiichi strike cancer drug pact worth up to $22 billion
- Trump pressured former Arizona governor to overturn 2020 election results: Sources
- Roche acquires Telavant from Roivant, adding experimental IBD treatment
- J&J lung cancer data amount to new salvo against AstraZeneca
- J&J lung cancer data amount to new salvo against AstraZeneca
- Roche acquires Telavant from Roivant, adding experimental IBD treatment
- Trump pressured former Arizona governor to overturn 2020 election results: Sources